EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deletion of phosphatidylethanolamine methyltransferase promotes the spontaneous development of hepatic steatosis, inflammation and fibrosis in young mice

Sathish Kumar Perumal iD, Ramachandran Rajamanickam iD, Madan Kumar Arumugam iD, Srinivas Chava iD, Ramesh Bellamkonda iD, Sundararajan Mahalingam iD, Natalia A Osna iD, Isis Trujillo-Gonzalez iD, Kurt W Fisher iD, Karuna Rasineni iD, Kusum K Kharbanda iD

Clinical Science · 11.06.2026

DOI: 10.1042/cs20250454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, online erschienen am 11.06.2026. Verfasst von Sathish Kumar Perumal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Service, Veterans Affairs Nebraska-Western Iowa Health Care System Omaha, Nebraska 68105, U.S.A. Hauptthemen laut MEDLINE: Phosphatidylethanolamine N-Methyltransferase, Liver Cirrhosis, Liver, Fatty Liver. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIAAA NIH HHS, HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphatidylethanolamine N-methyltransferase (PEMT) catalyzes the transfer of methyl groups to phosphatidylethanolamine (PE) to generate phosphatidylcholine (PC). PC produced de novo through this pathway is preferentially used for very‑low‑density lipoprotein assembly and is essential for its normal hepatic secretion as well as for bile acid detoxification. While human PEMT loss-of-function polymorphisms are linked to increased metabolic dysfunction-associated steatotic liver disease (MASLD) risk, the enzyme's role as a primary driver of progressive liver disease remains underexplored. We utilized PEMT knockout (PEMT KO) mice on a standard chow diet to model this deficiency. Histopathological analysis showed that while 2-month-old PEMT KO mice were protected, 6-month-old KOs of both sexes spontaneously developed extensive micro- and macrovesicular steatosis, parenchymal inflammation, and granulomatous inclusions. This severe, age-dependent pathology was confirmed by elevated hepatic triglyceride levels, bile acids, impaired methylation potential, and a cascade of secondary injuries, including increased oxidative stress, impaired proteasomal function, and the induction of cellular senescence markers. This bile acid toxicity and oxidative stress activated the central innate immune sensor, the NLRP3 inflammasome, driving pronounced macrophage infiltration and chronic inflammation. Picrosirius red staining and protein analysis confirmed the progression to severe pericellular fibrosis. Our study establishes that PEMT deficiency is sufficient to initiate and drive the complete progression from steatosis to advanced liver fibrosis, identifying PEMT as a critical metabolic checkpoint and a potent therapeutic target for mitigating progressive liver disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphatidylethanolamine N-MethyltransferaseLiver CirrhosisLiverFatty LiverAnimalsMice, KnockoutFemaleMaleOxidative StressInflammationDisease Models, AnimalMice, Inbred C57BLMiceBile Acids and SaltsGene Deletion

Stichwörter der Autor:innen

Phosphatidylethanolamine methyltransferasehepatic fibrosishepatic inflammationhepatic steatosisliver injuryphosphatidylcholine

Substanzen

Phosphatidylethanolamine N-MethyltransferasePEMT protein, mouseBile Acids and Salts

Autor:innen und Institutionen

  • Research Service, Veterans Affairs Nebraska-Western Iowa Health Care System Omaha, Nebraska 68105, U.S.A.
  • Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68198, U.S.A.
  • Center for Molecular and Nanomedical Sciences, Sathyabama Institute of Science and Technology, Chennai 600119, India.
  • Department of Biochemistry & Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska 68198, U.S.A.
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska 68198, U.S.A.
  • Department of Nutrition, Gillings School of Public Health, Nutrition Research Institute, University of North Carolina at Chapel Hill, Kannapolis, NC 28081, U.S.A.

ORCID-Profile: Sathish Kumar Perumal, Ramachandran Rajamanickam, Madan Kumar Arumugam, Srinivas Chava, Ramesh Bellamkonda, Sundararajan Mahalingam, Natalia A Osna, Isis Trujillo-Gonzalez, Kurt W Fisher, Karuna Rasineni, Kusum K Kharbanda

Förderung

  • BLRD VA
  • NIAAA NIH HHS
  • HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  • U.S. Department of Veterans Affairs (VA)

Zitieren

APA

Perumal, S. K., Rajamanickam, R., Arumugam, M. K., Chava, S., Bellamkonda, R., Mahalingam, S., Osna, N. A., Trujillo-Gonzalez, I., Fisher, K. W., Rasineni, K., & Kharbanda, K. K. (2026). Deletion of phosphatidylethanolamine methyltransferase promotes the spontaneous development of hepatic steatosis, inflammation and fibrosis in young mice. Clinical Science. https://doi.org/10.1042/cs20250454

Vancouver

Perumal SK, Rajamanickam R, Arumugam MK, Chava S, Bellamkonda R, Mahalingam S, et al. Deletion of phosphatidylethanolamine methyltransferase promotes the spontaneous development of hepatic steatosis, inflammation and fibrosis in young mice. Clinical Science. 2026. doi:10.1042/cs20250454

BibTeX
@article{Perumal2026,
  author = {Perumal, Sathish Kumar and Rajamanickam, Ramachandran and Arumugam, Madan Kumar and Chava, Srinivas and Bellamkonda, Ramesh and Mahalingam, Sundararajan and Osna, Natalia A and Trujillo-Gonzalez, Isis and Fisher, Kurt W and Rasineni, Karuna and Kharbanda, Kusum K},
  title = {Deletion of phosphatidylethanolamine methyltransferase promotes the spontaneous development of hepatic steatosis, inflammation and fibrosis in young mice},
  journal = {Clinical Science},
  year = {2026},
  doi = {10.1042/cs20250454}
}
Kostenlos starten →